190 related articles for article (PubMed ID: 28977875)
1. Expression of LAG-3 defines exhaustion of intratumoral PD-1
Yang ZZ; Kim HJ; Villasboas JC; Chen YP; Price-Troska T; Jalali S; Wilson M; Novak AJ; Ansell SM
Oncotarget; 2017 Sep; 8(37):61425-61439. PubMed ID: 28977875
[TBL] [Abstract][Full Text] [Related]
2. PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival.
Yang ZZ; Grote DM; Ziesmer SC; Xiu B; Novak AJ; Ansell SM
Blood Cancer J; 2015 Feb; 5(2):e281. PubMed ID: 25700246
[TBL] [Abstract][Full Text] [Related]
3. Mass Cytometry Analysis Reveals that Specific Intratumoral CD4
Yang ZZ; Kim HJ; Villasboas JC; Price-Troska T; Jalali S; Wu H; Luchtel RA; Polley MC; Novak AJ; Ansell SM
Cell Rep; 2019 Feb; 26(8):2178-2193.e3. PubMed ID: 30784598
[TBL] [Abstract][Full Text] [Related]
4. Differential Expression of Immune Checkpoint Modulators on In Vitro Primed CD4(+) and CD8(+) T Cells.
Sabins NC; Harman BC; Barone LR; Shen S; Santulli-Marotto S
Front Immunol; 2016; 7():221. PubMed ID: 27379090
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of Immune Checkpoint Molecules, PD-1 and LAG-3, on CD4+ and CD8+ T Cells after Gastric Cancer Surgery.
Takaya S; Saito H; Ikeguchi M
Yonago Acta Med; 2015 Mar; 58(1):39-44. PubMed ID: 26190896
[TBL] [Abstract][Full Text] [Related]
6. Characterization of age-associated exhausted CD8⁺ T cells defined by increased expression of Tim-3 and PD-1.
Lee KA; Shin KS; Kim GY; Song YC; Bae EA; Kim IK; Koh CH; Kang CY
Aging Cell; 2016 Apr; 15(2):291-300. PubMed ID: 26750587
[TBL] [Abstract][Full Text] [Related]
7. Diffuse large B-cell lymphoma (DLBCL) is infiltrated with activated CD8
Greenbaum AM; Fromm JR; Gopal AK; Houghton AM
Blood Res; 2022 Jun; 57(2):117-128. PubMed ID: 35551108
[TBL] [Abstract][Full Text] [Related]
8. PD-1 marks dysfunctional regulatory T cells in malignant gliomas.
Lowther DE; Goods BA; Lucca LE; Lerner BA; Raddassi K; van Dijk D; Hernandez AL; Duan X; Gunel M; Coric V; Krishnaswamy S; Love JC; Hafler DA
JCI Insight; 2016 Apr; 1(5):. PubMed ID: 27182555
[TBL] [Abstract][Full Text] [Related]
9. Targeting PD-1 and Tim-3 Pathways to Reverse CD8 T-Cell Exhaustion and Enhance Ex Vivo T-Cell Responses to Autologous Dendritic/Tumor Vaccines.
Liu J; Zhang S; Hu Y; Yang Z; Li J; Liu X; Deng L; Wang Y; Zhang X; Jiang T; Lu X
J Immunother; 2016 May; 39(4):171-80. PubMed ID: 27070448
[TBL] [Abstract][Full Text] [Related]
10. Selective expansion of a subset of exhausted CD8 T cells by alphaPD-L1 blockade.
Blackburn SD; Shin H; Freeman GJ; Wherry EJ
Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15016-21. PubMed ID: 18809920
[TBL] [Abstract][Full Text] [Related]
11. Imbalanced production of cytokines by T cells associates with the activation/exhaustion status of memory T cells in chronic HIV type 1 infection.
Nakayama K; Nakamura H; Koga M; Koibuchi T; Fujii T; Miura T; Iwamoto A; Kawana-Tachikawa A
AIDS Res Hum Retroviruses; 2012 Jul; 28(7):702-14. PubMed ID: 21902582
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction.
Trautmann L; Janbazian L; Chomont N; Said EA; Gimmig S; Bessette B; Boulassel MR; Delwart E; Sepulveda H; Balderas RS; Routy JP; Haddad EK; Sekaly RP
Nat Med; 2006 Oct; 12(10):1198-202. PubMed ID: 16917489
[TBL] [Abstract][Full Text] [Related]
13. Impaired functional responses in follicular lymphoma CD8
Gravelle P; Do C; Franchet C; Mueller S; Oberic L; Ysebaert L; Larocca LM; Hohaus S; Calmels MN; Frenois FX; Kridel R; Gascoyne RD; Laurent G; Brousset P; Valitutti S; Laurent C
Oncoimmunology; 2016; 5(10):e1224044. PubMed ID: 27990323
[TBL] [Abstract][Full Text] [Related]
14. Blockade of programmed death receptor-1 signaling restores expression of mostly proinflammatory cytokines in anergic cytomegalovirus-specific T cells.
Dirks J; Egli A; Sester U; Sester M; Hirsch HH
Transpl Infect Dis; 2013 Feb; 15(1):79-89. PubMed ID: 23176118
[TBL] [Abstract][Full Text] [Related]
15. [Regulation of T-cell immune exhaustion and cancer immunotherapy].
Eikawa S; Udono H
Gan To Kagaku Ryoho; 2014 Sep; 41(9):1066-70. PubMed ID: 25248889
[TBL] [Abstract][Full Text] [Related]
16. Synergistic combination therapy using cowpea mosaic virus intratumoral immunotherapy and Lag-3 checkpoint blockade.
Karan S; Jung E; Boone C; Steinmetz NF
Cancer Immunol Immunother; 2024 Feb; 73(3):51. PubMed ID: 38349406
[TBL] [Abstract][Full Text] [Related]
17. CD8+ T-cell subsets defined by expression of CD45 isoforms differ in their capacity to produce IL-2, IFN-gamma and TNF-beta.
Adamthwaite D; Cooley MA
Immunology; 1994 Feb; 81(2):253-60. PubMed ID: 7908892
[TBL] [Abstract][Full Text] [Related]
18. CD4 T Cell Depletion Substantially Augments the Rescue Potential of PD-L1 Blockade for Deeply Exhausted CD8 T Cells.
Penaloza-MacMaster P; Provine NM; Blass E; Barouch DH
J Immunol; 2015 Aug; 195(3):1054-63. PubMed ID: 26116499
[TBL] [Abstract][Full Text] [Related]
19. Programmed death-1 as a factor in immune exhaustion and activation in HIV infection.
Kaufmann DE; Walker BD
Curr Opin HIV AIDS; 2008 May; 3(3):362-7. PubMed ID: 19372991
[TBL] [Abstract][Full Text] [Related]
20. PD-1 and CD103 Are Widely Coexpressed on Prognostically Favorable Intraepithelial CD8 T Cells in Human Ovarian Cancer.
Webb JR; Milne K; Nelson BH
Cancer Immunol Res; 2015 Aug; 3(8):926-35. PubMed ID: 25957117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
